Company Ginemed S.r.l. with Fiscal Code 18422741
recorded a turnover of 2024 of
96.003,
with a net profit of
14.995
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Ginemed S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
38.642
40.205
32.823
34.995
34.731
29.478
41.433
39.625
51.711
96.003
Total Income - EUR
38.639
40.205
32.823
34.995
35.498
30.203
41.438
44.695
51.743
96.004
Total Expenses - EUR
33.728
37.736
27.080
46.499
30.129
29.962
39.373
41.490
55.355
76.424
Gross Profit/Loss - EUR
4.911
2.469
5.742
-11.504
5.369
241
2.066
3.205
-3.612
19.580
Net Profit/Loss - EUR
3.752
1.263
4.758
-12.407
4.534
-316
1.050
2.044
-4.412
14.995
Employees
1
1
2
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 86.7%, from 51.711 euro in the year 2023, to 96.003 euro in 2024.
The Net Profit increased by 14.995 euro, from 0 euro in 2023, to 14.995 in the last year.
Check the financial reports for the company - Ginemed S.r.l.
Financial Rating - GINEMED S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Ginemed S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Ginemed S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Ginemed S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
5.241 euro in 2024 which includes Inventories of
0 euro, Receivables of
1.198 euro and cash availability of
4.043 euro.
The company's Equity was valued at
11.649 euro, while total Liabilities amounted to
53.758 euro.
Equity increased by 14.995 euro, from -3.365 euro in 2023, to 11.649 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ginemed S.r.l.